oasmia.se
Oasmia - HemOasmia utvecklar en ny generation av läkemedel med fokus på human och veterinär onkologi.
http://www.oasmia.se/
Oasmia utvecklar en ny generation av läkemedel med fokus på human och veterinär onkologi.
http://www.oasmia.se/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
PAGES IN
THIS WEBSITE
6
SSL
EXTERNAL LINKS
12
SITE IP
138.68.86.111
LOAD TIME
0 sec
SCORE
6.2
Oasmia - Hem | oasmia.se Reviews
https://oasmia.se
Oasmia utvecklar en ny generation av läkemedel med fokus på human och veterinär onkologi.
oasmia.se
Oasmia - Kontaktuppgifter
http://www.oasmia.se/pages.asp?c_id=19
Du är alltid välkommen att kontakta oss. Raquo; Skriv ut. Oasmia Pharmaceutical AB, Vallongatan 1, 752 28 Uppsala. Växel 018-50 54 40, Fax 018-51 08 73, E-postadress info@oasmia.com. Org nr 556332-6676, Reuters.
Oasmia - Oasmia redovisar positiva resultat för Paclical® i en jämförande studie med Abraxane®
http://www.oasmia.se/news.asp?c_id=473
Oasmia redovisar positiva resultat för Paclical i en jämförande studie med Abraxane. New York, NY – 4:e augusti, 2015 – Oasmia Pharmaceutical redovisar idag positiva resultat från en jämförande studie med sitt cancerläkemedel Paclical och Abraxane, som marknadsförs av Celgene. Resultaten visar att båda produkterna har en liknande farmakokinetisk profil. Studien utfördes på kvinnor som drabbats av metastatisk bröstcancer. Om den jämförande studien med Paclical och Abraxane. Bröstcancer fortsätte...Denna s...
Oasmia - Pressmeddelande
http://www.oasmia.se/archive.asp?f_id=21
Kallelse till årsstämma för Oasmia Pharmaceutical AB. Läs mer ». Oasmia Pharmaceuticals årsredovisning offentliggjord. Läs mer ». Oasmia genomför en riktad emission av konvertibler om totalt 42 000 000 kronor. Läs mer ». Bokslutskommuniké för räkenskapsåret 1 maj 2015 – 30 april 2016. Läs mer ». Oasmia Pharmaceutical tidigarelägger datum för publicering av årsredovisning. Läs mer ». Läs mer ». Förtydligande till artikel i BioPharm Insight. Läs mer ». Läs mer ». Läs mer ». Läs mer ». Läs mer ». Uppdaterin...
Oasmia - Översikt
http://www.oasmia.se/sitemap.asp
Raquo; Human Health. Raquo; Länkar. Raquo; Marknad Human Health. Raquo; Animal Health. Raquo; Doxophos Vet. Raquo; För djurägare. Raquo; För veterinärer. Raquo; Länkar. Raquo; Marknad Animal Health. Raquo; Paccal Vet. Raquo; Amir Tatarevic (född 1971). Raquo; Anders Blom (född 1969). Raquo; Julian Aleksov (född 1965). Raquo; Mikael Asp (född 1962). Raquo; Amir Tatarevic. Raquo; Annette Ljungmark. Raquo; Dzianis Babrou. Raquo; Hans Sundin. Raquo; Henrik Rönnberg. Raquo; John Cosby. Raquo; Mikael Asp.
Oasmia - Ny vetenskaplig artikel om Paccal Vet
http://www.oasmia.se/news.asp?c_id=474
Ny vetenskaplig artikel om Paccal Vet. En översiktsartikel om Paccal Vet har nyligen publicerats i den renommerade tidskriften Journal of Veterinary Internal Medicine. Artikeln kan läsas i sin helhet på engelska här. Raquo; Skriv ut. Oasmia Pharmaceutical AB, Vallongatan 1, 752 28 Uppsala. Växel 018-50 54 40, Fax 018-51 08 73, E-postadress info@oasmia.com. Org nr 556332-6676, Reuters.
TOTAL PAGES IN THIS WEBSITE
6
Oasmia - Contact information
http://www.oasmia.com/pages.asp?c_id=19
You are always welcome to contact us. 46 18 50 54 40. 46 18-51 08 73. Oasmia investor page on RedChip. Raquo; Tell a friend. Oasmia Pharmaceutical AB, Vallongatan 1, SE-752 28 Uppsala, Sweden. Telephone: 46 18 50 54 40, Fax: 46 18 51 08 73, E-mail address info@oasmia.com. Corp Reg. No 556332-6676 Vat. No SE556332667601, Reuters.
Oasmia - Contact information
http://www.oasmia.de/pages.asp?c_id=19
You are always welcome to contact us. 46 18 50 54 40. 46 18-51 08 73. Oasmia investor page on RedChip. Raquo; Tell a friend. Oasmia Pharmaceutical AB, Vallongatan 1, SE-752 28 Uppsala, Sweden. Telephone: 46 18 50 54 40, Fax: 46 18 51 08 73, E-mail address info@oasmia.com. Corp Reg. No 556332-6676 Vat. No SE556332667601, Reuters.
Oasmia - New scientific article about Paccal Vet
http://www.oasmia.de/news.asp?c_id=378
New scientific article about Paccal Vet. A scientific review about Paccal Vet has recently been published in the Journal of Internal Veterinary Medicine. The article is available in its entirety here. Raquo; Tell a friend. Oasmia Pharmaceutical AB, Vallongatan 1, SE-752 28 Uppsala, Sweden. Telephone: 46 18 50 54 40, Fax: 46 18 51 08 73, E-mail address info@oasmia.com. Corp Reg. No 556332-6676 Vat. No SE556332667601, Reuters.
Oasmia - Press releases
http://www.oasmia.com/archive.asp?f_id=21
Notice convening the Annual General Meeting of Shareholders in Oasmia Pharmaceutical AB. Further reading ». The Oasmia Pharmaceutical Annual Report is now published. Further reading ». Oasmia successfully completes a private placement of new convertible instruments in a total amount of SEK 42,000,000. Further reading ». Year-end report for the fiscal year May 1, 2015 - April 30, 2016. Further reading ». Oasmia Pharmaceutical announces early publication of Annual Report. Further reading ». Oasmia Pharmace...
Oasmia - sitemap
http://www.oasmia.com/sitemap.asp
Raquo; Clinical Studies. Raquo; Human Health. Raquo; Market Human Health. Raquo; Animal Health. Raquo; Clinical Studies. Raquo; Doxophos Vet. Raquo; For companion animal owners. Raquo; For veterinarians. Raquo; Market Animal Health. Raquo; Paccal Vet. Raquo; Amir Tatarevic (born 1971). Raquo; Anders Blom (born 1969). Raquo; Julian Aleksov (born 1965). Raquo; Mikael Asp (born 1962). Raquo; Amir Tatarevic. Raquo; Annette Ljungmark. Raquo; Dzianis Babrou. Raquo; Hans Sundin. Raquo; Henrik Rönnberg. Raquo; C...
Oasmia - Press releases
http://www.oasmia.de/archive.asp?f_id=21
Notice convening the Annual General Meeting of Shareholders in Oasmia Pharmaceutical AB. Further reading ». The Oasmia Pharmaceutical Annual Report is now published. Further reading ». Oasmia successfully completes a private placement of new convertible instruments in a total amount of SEK 42,000,000. Further reading ». Year-end report for the fiscal year May 1, 2015 - April 30, 2016. Further reading ». Oasmia Pharmaceutical announces early publication of Annual Report. Further reading ». Oasmia Pharmace...
Oasmia - Oasmia Pharmaceutical Announces Positive Top-line Results for Paclical® From Head-to-Head Comparison Study with Abraxane®
http://www.oasmia.de/news.asp?c_id=377
Oasmia Pharmaceutical Announces Positive Top-line Results for Paclical From Head-to-Head Comparison Study with Abraxane. New York, NY – August 4, 2015 – Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, announced today the topline findings from a head-to-head comparison study of its lead human cancer product Paclical. And Celgene’s Abraxane. Ldquo;We believe our technology is superior to that of Abraxane. Oasmia believes these data strengthen its pos...
Oasmia - Oasmia Pharmaceutical Announces Positive Top-line Results for Paclical® From Head-to-Head Comparison Study with Abraxane®
http://www.oasmia.com/news.asp?c_id=377
Oasmia Pharmaceutical Announces Positive Top-line Results for Paclical From Head-to-Head Comparison Study with Abraxane. New York, NY – August 4, 2015 – Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, announced today the topline findings from a head-to-head comparison study of its lead human cancer product Paclical. And Celgene’s Abraxane. Ldquo;We believe our technology is superior to that of Abraxane. Oasmia believes these data strengthen its pos...
Oasmia - sitemap
http://www.oasmia.de/sitemap.asp
Raquo; Clinical Studies. Raquo; Human Health. Raquo; Market Human Health. Raquo; Animal Health. Raquo; Clinical Studies. Raquo; Doxophos Vet. Raquo; For companion animal owners. Raquo; For veterinarians. Raquo; Market Animal Health. Raquo; Paccal Vet. Raquo; Amir Tatarevic (born 1971). Raquo; Anders Blom (born 1969). Raquo; Julian Aleksov (born 1965). Raquo; Mikael Asp (born 1962). Raquo; Amir Tatarevic. Raquo; Annette Ljungmark. Raquo; Dzianis Babrou. Raquo; Hans Sundin. Raquo; Henrik Rönnberg. Raquo; C...
Oasmia - Glossary
http://www.oasmia.com/pages.asp?c_id=52
A substance that counteracts the effect of another substance. Cancer antigen 125, diagnostic tumour marker. The treatment of cancer with cytostatics. Drugs that are used to inhibit tumor growth. European Medicines Agency. The European regulatory drug agency. Carrier, inactive substance used as carrier of an active pharmaceutical ingredient. Food and Drug Administration. The US regulatory drug agency. Good Clinical Practice. International quality guidelines for clinical studies. A form of skin cancer.
TOTAL LINKS TO THIS WEBSITE
12
oasmedia.com.tr
0532 708 79 93. 0531 965 11 15. TÜM MÜZİK LİSANSLAMA İHTİYAÇLARINIZ İÇİN. Read our greengeeks review. If you need a business class web hosting. Designed by Joomla Hosting.
OAS METAL İNŞAAT VE İNŞAAT DEKARASYON MALZEME PVC ALÜMİNYUM
TÜRKERLER İNŞAAT İZKA İNŞAAT ORTAKLIĞI PARK YAŞAM MAVİŞEHİR. İZKA İNŞAAT - KÜTAHYA MODERN 200 DAİRE. İZKA İNŞAAT - UŞAK TOKİ 797 ADET İŞYERİ. İZKA İNŞAAT - DİY-MAR İNŞAAT ORTAKLIĞI ADANA BÖLGE ADLİYESİ. İZMİR - KORDON PROJESİ. İZMİR - GÜMÜLDÜR SEASİDE 105 DAİRE. İZMİR ADNAN MENDERES HAVALİMANI DIŞ HATLAR TERMİNALİ KROM MERDİVEN KORKULUKLARI 2006. İZMİR MAVİŞEHİR - DOĞA KOLEJİ. Balkonlara,merdivenlere,havuz kenarlarına ve inşaatlarda emniyet ve hoş görüntü sağlar. Küpeştede ara hat boruları kullanmak yeri...
OAS Management - Home Page
Order a Resale Document. Common Documents and Forms. OAS Management, LLC. 8220;Serving Community Associations” since 1984, was formed with the goal of offering exceptional service at fair and competitive prices. We have been providing personalized financial and management services to Homeowner Associations in Sonoma County for over 25 years. We currently serve 42 Homeowner Associations in Sonoma County. We have a conscientious, friendly staff and look forward to working with your Homeowner Associatio...
Home - Oasmia
Vision & goals. Research & Development. Code of Business Conduct and Ethics. Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole. On June 15th, Oasmia Pharmaceutical AB held a Capital Markets Day in Stockholm. The presentation is available here. Our vision is to improve the quality for treatment of severe diseases. Researching and developing next generation medicines, our focus is on advancing oncology treatments.
Oasmia - Home
Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology. Further reading ». Our main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs. Further reading ». Animal Health develops and improves existing medical treatments focusing on oncology. Further reading ». New scientifc article about Paccal Vet. Further reading ». Further reading ». Further reading ». News archive ».
Oasmia - Hem
Vår vision är att förbättra behandlingen av svåra sjukdomar. Vi arbetar med framtidens mediciner, främst inom onkologi. Läs mer ». Avdelningen Human Health ser som sin uppgift att utveckla nya läkemedel där det finns omfattande medicinska behov. Läs mer ». Avdelningen Animal Health arbetar med utveckling och förbättring av nuvarande behandlingsmetoder med fokus på onkologi. Läs mer ». Ny vetenskaplig artikel om Paccal Vet. Läs mer ». Läs mer ». Läs mer ». Org nr 556332-6676, Reuters.
Orthodontics OKC and Edmond | Invisalign | Orthodontic Associates - Orthodontic Associates Oklahoma City | East Edmond | West Edmond
Providing beautiful, healthy smiles to the Oklahoma community. Read about a variety of services we offer to patients. Changing lives one smile at a time. Read more about Orthodontic Associates and the orthodontists who are passionate about you. Healthy, confident smiles for kids and adults. Call now to schedule your first free visit! Schedule Your Free Consultation. Modern comfortable orthodontic treatment options. Read more about Invisalign, braces and our other orthodontic services. Serving orthodontic...
Ольга Смолина | http://permregion.wordpress.com/%D1%84%D1%83%D0%BD%D0%BA%D1%86%D0%B8%D0%BE%D0%BD%D0%B0%D0%BB%D1%8C%D0%BD%D0%BE-%D1%86%D0%B5%D0%BB%D0%B5%D0%B2%D0%B0%D1%8F-%D0%BC%D0%BE%D0%B4%D0%B5%D0%BB%D1%8C/%D1%80%D0%B0%D0%B7%D0%B2%D0%B8%D1%82%D0%B8%D0%B5-
124; Comments RSS. Проект Шаг к цели. Май 5, 2012. Восемь лет. Итоги. Март 11, 2012. Формирование ленты новостей на основе виджета RSS. Март 6, 2012. Неделя 02.07.12-06.07.12. Posted on Июль 6, 2012. 013714.2.2.5. Формирование реестра заявок на оплату расходов в программе АРМ Бюджетополучатель. Формировала акт приема-сдачи документов (на оплату) в централизованную бухгалтерию. Проводилась работа с получателями средств краевого бюджета по:. Уточнению реквизитов получателя средств;. 124; Leave a comment.
SOCIAL ENGAGEMENT